Abstract
A series of N-substituted phthalimide derivatives were synthesized based on a pharmacophore study of paecilocin A (a natural PPAR-γ agonist) and synthetic leads. The introduction of hydrophilic and hydrophobic groups to the phthalimide skeleton yielded compounds 3-14. Compound 7 showed significant PPAR-γ activation in a luciferase assay using rat liver Ac2F cells. Docking simulations showed that a free hydroxyl group on the phthalimide head and a suitable hydrophilic tail, including a phenyl linker, were beneficial for PPAR-γ activation. Compound 7 and rosiglitazone concentration-dependently activated PPAR-γ with EC50 values of 0.67 μM and 0.028 μM, respectively. These phthalimide derivatives could be further investigated as a new class of PPAR-γ ligands.
| Original language | English |
|---|---|
| Pages (from-to) | 926-939 |
| Number of pages | 14 |
| Journal | Marine Drugs |
| Volume | 12 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 14 Life Below Water
Keywords
- Cell proliferation
- Diabetes
- Docking simulation
- Luciferase assay
- PPAR-γ
- Phthalimide
Fingerprint
Dive into the research topics of 'Synthesis of PPAR-γ activators inspired by the marine natural product, paecilocin A'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver